Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Top UK medical cannabis firm acquires Spanish producer Sanoid

August 18, 2021 Research and Development

Grow Group, a UK medical cannabis firm, announced on Wednesday the acquisition of Sanoid Isolates, a key medical cannabis producer …
News

Sackler family refuse to pay billions for opioid crisis unless given immunity

August 18, 2021 Research and Development

The Sackler family, the billionaire owners of Purdue Pharma, vowed in court on Tuesday that unless they are granted legal …
News

Aspirin trialled as potential treatment for aggressive form of breast cancer

August 18, 2021 Research and Development

Aspirin is being trialled in combination with immunotherapy drugs as part of a potential new treatment for an aggressive form …
News

Bidding war for Australian mRNA vaccine production

August 18, 2021 Research and Development

Biotech company IDT has put forward a proposal to the Australian federal government to produce 100 million mRNA vaccines from …
News

Anger as NICE pauses advice on chronic fatigue syndrome therapy

August 18, 2021 Research and Development

NICE has paused publication of its updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome …
News

Cannabidiol gains MHRA approval as adjunctive treatment of seizures

August 11, 2021 Research and Development

GW Pharmaceuticals has announced that is has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for …
News
andrei_r_-_shutterstock_1935537274_720

Janssen’s MS treatment Ponvory is granted UK marketing authorisation

August 11, 2021 Research and Development

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted Marketing Authorisation in Great Britain for PONVORY (ponesimod) for the …
News

Sputnik V vaccine 13% less effective against Delta than originally reported

August 11, 2021 Medical Communications, Research and Development

Russian health officials have announced that the Sputnik V COVID vaccine is 83% effective against the Delta variant on Wednesday, …
News
cdc-un8tv9pw2ik-unsplash_1

More than 75% of UK adults have been double jabbed

August 11, 2021 Research and Development

More than 75% of adults living in the UK have now received both doses of the vaccine, as announced by …
News

Moderna and Canada to collaborate on mRNA manufacturing

August 11, 2021 Manufacturing and Production, Research and Development

Moderna will build a messenger RNA (mRNA) vaccine manufacturing facility in Canada, which will include access to Moderna’s mRNA development …
News
gilead-sciences

Kite receives positive recommendation from SMC for CAR T therapy

August 10, 2021 Manufacturing and Production, Research and Development

Kite has announced a positive recommendation from the Scottish Medicines Consortium (SMC) on the company’s Healthcare Technology Assessment for Tecartus, …
News
laboratory-testing-az

Researchers develop injectable hydrogel to combat Parkinson’s

August 10, 2021 Medical Communications, Research and Development

An Australian research team has developed a hydrogel that can be used as a one-off intervention to treat Parkinson’s disease, …
News

AI system may be able to detect dementia in a day

August 10, 2021 Manufacturing and Production, Medical Communications, Research and Development

Researchers from Cambridge University and The Alan Turing Institute have developed an artificial intelligence (AI) system that can diagnose dementia …
News

Researchers develop new method to kill bacteria on medical implants

August 9, 2021 Medical Communications, Research and Development, Sales and Marketing

Researchers from Chalmers University of Technology, Sweden, have developed a new method to prevent bacterial infections relating to medical implants …
News
az

First new adult CDK treatment in 20 years gains UK and EU approval

August 9, 2021 Medical Communications, Research and Development, Sales and Marketing

AstraZeneca has announced the EU approval of Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, alongside a licence extension from …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026